Levothyroxine Sodium
NDC 68071-3692, Levothyroxine Sodium, tablet, from NuCarePharmaceuticals, Inc..
- Product NDC
- 68071-3692
- Status
- Listed
- Labeler
- NuCarePharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209713
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68071-3692 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM.125 mg/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68071-3692-9 | 68071369209 | 90 TABLET in 1 BOTTLE (68071-3692-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2380859a-5b65-f88f-e063-6394a90aa4e2
Use it
Look up 68071-3692 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68071-3692 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68071-3692. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.